Literature DB >> 7251134

Ability of an avirulent mutant of Vibrio cholerae to colonize in the infant mouse upper bowel.

S P Sigel, R A Finkelstein, C D Parker.   

Abstract

Vibrio cholerae strain 3083 (biotype El Tor, serotype Ogawa) and Texas Star-SR (SR), a mutant derived from 3083 that produces the B (binding) but not the A (toxic) subunit of choleragen, were compared in their abilities to: (i) associate with the infant mouse upper bowel; (ii) survive and multiple there; and (iii) induce diarrhea. Vibrios labeled with 35SO4 were used to determine association with the upper bowel and ability to multiply. The parental strain associated significantly better than SR, although viable mutant cells were found in the infant mouse intestine 16 to 18 h after challenge. Addition of exogenous toxin enhanced the rate at which labeled SR (but not 3083) was cleared, further suggesting that SR associates less well with the upper bowel. Both SR and 3083 multiplied in the upper bowel but, due perhaps to slight net killing during the first 3 h and its more rapid rate of clearance, SR achieved a population size only 10% that of 3083 by 8 h postchallenge. Strain 3083 elicited diarrhea in infant mice but SR did not, even after 10 successive passages through the infant mouse intestine. Strain SR was slightly temperature sensitive at 37 and 40 degrees C. Its potential use as a live vaccine is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7251134      PMCID: PMC351469          DOI: 10.1128/iai.32.2.474-479.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.

Authors:  T Honda; R A Finkelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

2.  Experimental cholera in infant rabbits: a method for chemotherapeutic investigation.

Authors:  N K DUTTA; M K HABBU
Journal:  Br J Pharmacol Chemother       Date:  1955-06

3.  Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice.

Authors:  V Baselski; R Briggs; C Parker
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

4.  In vivo and in vitro characterization of virulence-deficient mutants of Vibrio cholerae.

Authors:  V S Baselski; R A Medina; C D Parker
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

5.  Survival and multiplication of Vibrio cholerae in the upper bowel of infant mice.

Authors:  V S Baselski; R A Medina; C D Parker
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

6.  Membrane-bound enterotoxin of Vibrio cholerae.

Authors:  P B Fernandes; M E Bayer
Journal:  J Gen Microbiol       Date:  1977-12

7.  Studies on toxinogenesis in Vibrio cholerae. III. Characterization of nontoxinogenic mutants in vitro and in experimental animals.

Authors:  R K Holmes; M L Vasil; R A Finkelstein
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

8.  Vibrio cholerae adherence and colonization in experimental cholera: electron microscopic studies.

Authors:  E T Nelson; J D Clements; R A Finkelstein
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

9.  Intestinal distribution of Vibrio cholerae in orally infected infant mice: kinetics of recovery of radiolabel and viable cells.

Authors:  V S Baselski; C D Parker
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  In vivo evaluation of pathogenicity of clinical and environmental isolates of Vibrio cholerae.

Authors:  S P Sigel; S Lanier; V S Baselski; C D Parker
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

View more
  4 in total

1.  Compared colonizing and immunizing efficiency of toxinogenic (A+ B+) Vibrio cholerae and an A- B+ mutant (Texas Star-SR) studied in adult rabbits.

Authors:  E Tokunaga; W C Cray; N F Pierce
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

2.  Quantitative determination of bacterial replication in vivo.

Authors:  A Morris Hooke; D O Sordelli; M C Cerquetti; A J Vogt
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

3.  Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine.

Authors:  M Boesman-Finkelstein; R A Finkelstein
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

4.  Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota.

Authors:  Bärbel Stecher; Riccardo Robbiani; Alan W Walker; Astrid M Westendorf; Manja Barthel; Marcus Kremer; Samuel Chaffron; Andrew J Macpherson; Jan Buer; Julian Parkhill; Gordon Dougan; Christian von Mering; Wolf-Dietrich Hardt
Journal:  PLoS Biol       Date:  2007-10       Impact factor: 8.029

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.